Search research articles
Contact Us
Filters
Showing results (1-10 of 111) with videos related to
Page
of 12
Sort By:
Journal of Virology
|
May 1, 2009
Onset of human cytomegalovirus replication in fibroblasts requires the presence of an intact vimentin cytoskeleton
Matthew S Miller, Laura Hertel
Cell
|
April 15, 2014
Peering into the crystal ball: influenza pandemics and vaccine efficacy
Matthew S Miller, Peter Palese
Cytokine
|
April 24, 2018
Reviewing the evidence for viruses as environmental risk factors for ALS: A new perspective
Daniel B Celeste, Matthew S Miller
Future Microbiology
|
October 1, 2011
An unhealthy relationship: viral manipulation of the nuclear receptor superfamily
Matthew S Miller, Joe S Mymryk
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 28, 2020
Age-Specific Incidence of Influenza A Responds to Change in Virus Subtype Dominance
Alain Gagnon, Enrique Acosta, Matthew S Miller
Methods (San Diego, Calif.)
|
May 11, 2015
Measuring the neutralization potency of influenza A virus hemagglutinin stalk/stem-binding antibodies in polyclonal preparations by microneutralization assay
Wenqian He, Caitlin E Mullarkey, Matthew S Miller
Trends in Microbiology
|
May 16, 2020
Bat Influenza Viruses: Making a Double Agent of MHC Class II
Arinjay Banerjee, Karen L Mossman, Matthew S Miller
Molecular Pharmaceutics
|
August 14, 2020
Engineered Nanoparticle Applications for Recombinant Influenza Vaccines
Zachary R Sia, Matthew S Miller, Jonathan F Lovell
Cytokine
|
October 5, 2016
Abnormal regulation of the antiviral response in neurological/neurodegenerative diseases
Mannie Man Wai Lam, Jonathan P Mapletoft, Matthew S Miller
Vaccine
|
September 26, 2025
Rationalizing recommendations for influenza and COVID-19 vaccines
Jessica A Breznik, Matthew S Miller, Dawn M E Bowdish
Page
of 12
Search research articles
Search
Showing results (1-10 of 111) with videos related to
Sort By:
Page
of 12
Journal of Virology
|
May 1, 2009
Onset of human cytomegalovirus replication in fibroblasts requires the presence of an intact vimentin cytoskeleton
Matthew S Miller, Laura Hertel
Cell
|
April 15, 2014
Peering into the crystal ball: influenza pandemics and vaccine efficacy
Matthew S Miller, Peter Palese
Cytokine
|
April 24, 2018
Reviewing the evidence for viruses as environmental risk factors for ALS: A new perspective
Daniel B Celeste, Matthew S Miller
Future Microbiology
|
October 1, 2011
An unhealthy relationship: viral manipulation of the nuclear receptor superfamily
Matthew S Miller, Joe S Mymryk
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 28, 2020
Age-Specific Incidence of Influenza A Responds to Change in Virus Subtype Dominance
Alain Gagnon, Enrique Acosta, Matthew S Miller
Methods (San Diego, Calif.)
|
May 11, 2015
Measuring the neutralization potency of influenza A virus hemagglutinin stalk/stem-binding antibodies in polyclonal preparations by microneutralization assay
Wenqian He, Caitlin E Mullarkey, Matthew S Miller
Trends in Microbiology
|
May 16, 2020
Bat Influenza Viruses: Making a Double Agent of MHC Class II
Arinjay Banerjee, Karen L Mossman, Matthew S Miller
Molecular Pharmaceutics
|
August 14, 2020
Engineered Nanoparticle Applications for Recombinant Influenza Vaccines
Zachary R Sia, Matthew S Miller, Jonathan F Lovell
Cytokine
|
October 5, 2016
Abnormal regulation of the antiviral response in neurological/neurodegenerative diseases
Mannie Man Wai Lam, Jonathan P Mapletoft, Matthew S Miller
Vaccine
|
September 26, 2025
Rationalizing recommendations for influenza and COVID-19 vaccines
Jessica A Breznik, Matthew S Miller, Dawn M E Bowdish
Page
of 12